Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib
Clinical trial NCT01478373 · COMPLETED
Trial details
- NCT number
- NCT01478373
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-07-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.